Anand V Ramanathan, MD
Disclosures: Nothing to disclose










Home Address:              1388 Urban Drive

              Darien, Illinois  60561


Office Address:              Midwest Heart Foundation               Midwest Heart Specialists office              Immediate Past Address:

              1919 S. Highland Avenue              Edward Cardiovascular Institute               Midwest Heart Specialists

              Building B ; Suite 201              801 S. Washington St.-4th Floor              120 Spalding, Suite 206             

              Lombard, Illinois  60148              Naperville, Illinois  60540              Naperville, Illinois  60540              telephone:  630/932-2165              telephone:  630/527-2730

              telefax:  630/268-9609


Date of Birth:              June 27, 1967


Citizenship:              U.S.A.


Marital Status:              Married




1988  B.S.               University of North Carolina, Chapel Hill, North Carolina

                            B. S. Chemistry with Honors


1992  M.D.              University of North Carolina, Chapel Hill, North Carolina



Postgraduate Training and Fellowship Appointments:


1992-1995              Resident in Internal Medicine, Washington University/Barnes Hospital, St. Louis, Missouri


1995-1998              Fellow in General Cardiology, Baylor College of Medicine, Houston, Texas


1998-1999              Fellow in Interventional Cardiology, Baylor College of Medicine, Houston, Texas


2003                            Fellow in Cardiovascular Magnetic Resonance Imaging, Washington University, St. Louis, Missouri, Level II



Licensure and Board Certification:


1995-present              Texas Medical Licensure

1999-present              Illinois Medical Licensure                            036-100269

Licensure and Board Certification (continued):


1995                            American Board of Internal Medicine

                               Certificate #163804


1998                            American Board of Internal Medicine, Subspecialty Board of Cardiovascular Diseases

                               Certificate #163804 


1999                            American Board of Internal Medicine, Added Qualifications in Interventional Cardiology

                                Certificate #163804



Honors and Awards:


Phi Eta Sigma Honor Society

Merck Index Award for Excellence in Chemistry, 1988

Honor’s Thesis, 1988

Foreign Fellowship Research Award, 1989

NIH Research Grant, 1989



Society Membership:


American Medical Association

American College of Cardiology              Fellowship status:  08/31/01

Houston Cardiology Society

Society for Cardiac Angiography and Interventions (SCA&I)



Hospital Appointments:


1999-present              Consulting Cardiologist:

                            Edward Hospital, Naperville, Illinois

                            Central DuPage Hospital, Winfield, Illinois

                            Good Samaritan Hospital, Downers Grove, Illinois

                            Elmhurst Memorial Hospital, Elmhurst, Illinois



Research Experience:


Platelet GPIIb/IIIa receptors: 

  • Reversal of the Platelet Effects of Abciximab
  • Effectiveness of Dosing Abciximab in Emergency  Versus Planned Interventions
  • Meta-analysis of Diabetics and GPIIb/IIIa Inhibitors
  • Expression of Platelet Derived Micro-particles in Diabetics After Coronary Intervention and Abciximab Administration

Research Experience (continued):


Principal Investigator

A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting with Acute Coronary Syndromes (ACS).  Aventis Pharmaceuticals

Protocol Number ENO.GMA.301.  IND# 31532



A Randomized, Open-Label, Multicenter Pilot Study Evaluating the Safety and Efficacy of Pharmacomechanical Thrombolysis Combined with GPIIb/IIIa Inhibition in Acute Myocardial Infarction



TAXUS ARRIVE 2: Multi-Center Safety Surveillance Program



“A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Dose- Ranging Study to Evaluate the Safety and Efficacy of BO-653 in Prevention of Post-Angioplasty Restonosis in stented Lesions.”


Original Publications/Abstracts/Presentations:


1.     Ramanathan A, Harrison W:  Further characterization of ALDH III.  Honor’s Thesis, University of North Carolina, 1988


2.     Guest T, Ramanathan A, Teuter P, et al:  Myocardial injury critically ill patients.  JAMA 273:1945-1949, 1995.


3.     Blaustein A, Ramanathan A, Zogbhi W:  Tricuspid valve disease.  Cardiology Clinics 16(3):551-72, 1998.


4.     Ramanathan A, Kleiman N:  Review of GPIIb/IIIa inhibitors and angioplasty.  Indian Heart Journal 50 (Suppl 1):45-56, 1998.


5.     Ramanathan A, Miller DP, Kleinman N:  Effects of GPIIb-IIIa antagonists in patients with diabetes:  A meta-analysis.  Abstract presentation, American College of Cardiology, 1999.


6.              Isaac JC, Trenth MG, Ramanathan AV, et al:  The effect of drug affinity on reversal of glycoprotein IIb/IIIa antagonists using platelet transfusion.  Abstract presentation, American College of Cardiology, 2000.


7.              Clark SE, Stephan WJ, Ramanathan AV, et al:  Percutaneous catheter-based septal closure using transesophageal echocardiography and conscious sedation.  Catheter Cardiovasc Interventions, B-16, May 2003.  Poster presentation, the 26th Annual Scientific Sessions of the Society for Cardiac Angiography and Intervention, Boston, Massachusetts, May 2003.